Esthesioneuroblastoma: The Massachusetts Eye and Ear Infirmary and Massachusetts General Hospital experience with craniofacial resection, proton beam radiation, and chemotherapy

Skull Base

Volumn 18, Issue 5, 2008, Pages 327-336

  Nichols, Anthony C ^a   Chan, Annie W ^b   Curry, William T ^b   Barker II, Fred G ^a   Deschler, Daniel G ^a   Lin, Derrick T ^a  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Craniofacial resection; Esthesioneuroblastoma; Proton radiation

Indexed keywords

ANTIBIOTIC AGENT; CARBOPLATIN; CISPLATIN; ETOPOSIDE;

ABDUCENS NERVE PARALYSIS; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BONE GRAFT; BRAIN INJURY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DIGESTIVE TRACT INTUBATION; DISEASE FREE SURVIVAL; EPIPHORA; ESTHESIONEUROBLASTOMA; FEMALE; FOLLOW UP; GENERAL HOSPITAL; HUMAN; KAPLAN MEIER METHOD; LIQUORRHEA; MALE; METASTASIS; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NOSE OBSTRUCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PNEUMOCEPHALUS; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROTON THERAPY; PTOSIS; RADIATION DOSE; RETROSPECTIVE STUDY; TERTIARY HEALTH CARE; TREATMENT OUTCOME; TREATMENT RESPONSE; UNITED STATES; WOUND INFECTION;

EID: 54349116122     PISSN: 15315010     EISSN: 15320065     Source Type: Journal    
DOI: 10.1055/s-2008-1076098     Document Type: Article

References (33)

1. Berger L, Luc R, Richard D. L'esthésioneuroépithé liome olfactif. Bull Assoc Fr Etude Cancer 1924;13:410-421
2. Bhattacharyya N, Thornton AF, Joseph MP, Goodman ML, Amrein PC. Successful treatment of esthesioneuroblastoma and neuroendocrine carcinoma with combined chemotherapy and proton radiation: results in 9 cases. Arch Otolaryngol Head Neck Surg 1997;123:34-40
3. Dulguerov P, Allal AS, Calcaterra TC. Esthesioneuroblastoma: a meta-analysis and review. Lancet Oncol 2001;2:683-690
4. Levine PA, Gallagher R, Cantrell RW. Esthesioneuroblastoma: reflections of a 21-year experience. Laryngoscope 1999;109:1539-1543
5. Nishimura H, Ogino T, Kawashima M, et al. Protonbeam therapy for olfactory neuroblastoma. Int J Radiat Oncol Biol Phys 2007;68:758-762
6. Simon JH, Zhen W, McCulloch TM, et al. Esthesioneuroblastoma: the University of Iowa experience 1978-1998. Laryngoscope 2001;111:488-493
7. Dias FL, Sa GM, Lima RA, et al. Patterns of failure and outcome in esthesioneuroblastoma. Arch Otolaryngol Head Neck Surg 2003;129:1186-1192
8. Dulguerov P, Calcaterra T. Esthesioneuroblastoma: the UCLA experience 1970-1990. Laryngoscope 1992;102:843-849
9. Foote RL, Morita A, Ebersold MJ, et al. Esthesioneuroblastoma: the role of adjuvant radiation therapy. Int J Radiat Oncol Biol Phys 1993;27:835-842
10. Irish J, Dasgupta R, Freeman J, et al. Outcome and analysis of the surgical management of esthesioneuroblastoma. J Otolaryngol 1997;26:1-7
11. Suit H, Goldberg S, Niemierko A, et al. Proton beams to replace photon beams in radical dose treatments. Acta Oncol 2003;42:800-808
12. Gay E, Sekhar LN, Rubinstein E, et al. Chordomas and chondrosarcomas of the cranial base: results and follow-up of 60 patients. Neurosurgery 1995;36:887-896; discussion 896-887
13. Munzenrider JE, Liebsch NJ. Proton therapy for tumors of the skull base. Strahlenther Onkol 1999;175(suppl 2):57-63
14. Pommier P, Liebsch NJ, Deschler DG, et al. Proton beam radiation therapy for skull base adenoid cystic carcinoma. Arch Otolaryngol Head Neck Surg 2006;132:1242-1249
15. Kaplan EM. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958;53:457-481
16. Kadish S, Goodman M, Wang CC. Olfactory neuroblastoma: a clinical analysis of 17 cases. Cancer 1976;37:1571-1576
17. Levine PA, Scher RL, Jane JA, et al. The craniofacial resection - eleven-year experience at the University of Virginia: problems and solutions. Otolaryngol Head Neck Surg 1989;101:665-669
18. Rosenthal SJ, Gall KP, Jackson M, Thornton AF Jr. A precision cranial immobilization system for conformal stereotactic fractionated radiation therapy. Int J Radiat Oncol Biol Phys 1995;33:1239-1245
19. Urie M, Goitein M, Wagner M. Compensating for heterogeneities in proton radiation therapy. Phys Med Biol 1984;29:553-566
20. National Cancer Institute. Common Terminology Criteria for Adverse Events v3.0 (CTCAE). Cancer Therapy Evaluation Program Web site. Available at: http://ctep.cancer.gov/reporting/ctc.html
21. Goldsweig HG, Sundaresan N. Chemotherapy of recurrent esthesioneuroblastoma: case report and review of the literature. Am J Clin Oncol 1990;13:139-143
22. McElroy EA Jr, Buckner JC, Lewis JE. Chemotherapy for advanced esthesioneuroblastoma: the Mayo Clinic experience. Neurosurgery 1998;42:1023-1027; discussion 1027-1028
23. Resto VA, Eisele DW, Forastiere A, et al. Esthesioneuroblastoma: the Johns Hopkins experience. Head Neck 2000;22:550-558
24. Lund VJ, Howard D, Wei W, Spittle M. Olfactory neuroblastoma: past, present, and future? Laryngoscope 2003;113:502-507
25. Polonowski JM, Brasnu D, Roux FX, Bassot V. Esthesioneuroblastoma: complete tumor response after induction chemotherapy. Ear Nose Throat J 1990;69:743-746
26. Morita A, Ebersold MJ, Olsen KD, et al. Esthesioneuroblastoma: prognosis and management. Neurosurgery 1993;32:706-714; discussion 714-715
27. Argiris A, Dutra J, Tseke P, Haines K. Esthesioneuroblastoma: the Northwestern University experience. Laryngoscope 2003;113:155-160
28. Constantinidis J, Steinhart H, Koch M, et al. Olfactory neuroblastoma: the University of Erlangen-Nuremberg experience 1975-2000. Otolaryngol Head Neck Surg 2004;130:567-574
29. McLean JN, Nunley SR, Klass C, et al. Combined modality therapy of esthesioneuroblastoma. Otolaryngol Head Neck Surg 2007;136:998-1002
30. Loy AH, Reibel JF, Read PW, et al. Esthesioneuroblastoma: continued follow-up of a single institution's experience. Arch Otolaryngol Head Neck Surg 2006;132:134-138
31. Austin JR, Cebrun H, Kershisnik MM, et al. Olfactory neuroblastoma and neuroendocrine carcinoma of the anterior skull base: treatment results at the M.D. Anderson cancer center. Skull Base Surg 1996;6:1-8
32. Wade PM Jr, Smith RE, Johns ME. Response of esthesioneuroblastoma to chemotherapy: report of five cases and review of the literature. Cancer 1984;53:1036-1041
33. Hwang SK, Paek SH, Kim DG, et al. Olfactory neuroblastomas: survival rate and prognostic factor. J Neurooncol 2002;59:217-226